Serum and urine analyses for renal function (n = 12 per group)
. | Wild-type controls . | Ctns−/− controls . | WT BMCs . | Ctns−/− BMCs . | WT MSCs . |
---|---|---|---|---|---|
Serum | |||||
Creatinine, mg/dL | 0.34 ± 0.06 | 0.49 ± 0.30*† | 0.35 ± 0.07 | 0.43 ± 0.10*† | 0.38 ± 0.11 |
Creatinine clearance, μL/min | 79.40 ± 74.24 | 32.28 ± 42.58 | 65.65 ± 72.34 | 43.04 ± 34.46 | 85.35 ± 64.60 |
Urea, mg/dL | 36.54 ± 1.55 | 56.92 ± 18.41*† | 23.83 ± 19.62 | 74.95 ± 17.32*† | 41.98 ± 4.85† |
Phosphate, mg/dL | 18.31 ± 3.06 | 23.09 ± 4.70† | 10.95 ± 6.82 | 10.57 ± 7.53 | 11.86 ± 6.35 |
Alkaline phophatase, IU/L | 60.54 ± 23.57 | 67.35 ± 26.75 | 75.77 ± 21.10 | 67.76 ± 18.10 | 55.73 ± 16.20 |
Urine | |||||
Phosphate, μmol/24 h | 3.50 ± 2.29 | 11.00 ± 4.90*† | 3.75 ± 2.35 | 2.70 ± 2.87 | 5.11 ± 3.29 |
Protein, mg/24 h | 10.16 ± 6.21 | 17.28 ± 8.45 | 9.37 ± 6.91 | 8.35 ± 4.35 | 11.43 ± 7.08 |
. | Wild-type controls . | Ctns−/− controls . | WT BMCs . | Ctns−/− BMCs . | WT MSCs . |
---|---|---|---|---|---|
Serum | |||||
Creatinine, mg/dL | 0.34 ± 0.06 | 0.49 ± 0.30*† | 0.35 ± 0.07 | 0.43 ± 0.10*† | 0.38 ± 0.11 |
Creatinine clearance, μL/min | 79.40 ± 74.24 | 32.28 ± 42.58 | 65.65 ± 72.34 | 43.04 ± 34.46 | 85.35 ± 64.60 |
Urea, mg/dL | 36.54 ± 1.55 | 56.92 ± 18.41*† | 23.83 ± 19.62 | 74.95 ± 17.32*† | 41.98 ± 4.85† |
Phosphate, mg/dL | 18.31 ± 3.06 | 23.09 ± 4.70† | 10.95 ± 6.82 | 10.57 ± 7.53 | 11.86 ± 6.35 |
Alkaline phophatase, IU/L | 60.54 ± 23.57 | 67.35 ± 26.75 | 75.77 ± 21.10 | 67.76 ± 18.10 | 55.73 ± 16.20 |
Urine | |||||
Phosphate, μmol/24 h | 3.50 ± 2.29 | 11.00 ± 4.90*† | 3.75 ± 2.35 | 2.70 ± 2.87 | 5.11 ± 3.29 |
Protein, mg/24 h | 10.16 ± 6.21 | 17.28 ± 8.45 | 9.37 ± 6.91 | 8.35 ± 4.35 | 11.43 ± 7.08 |
Wild-type controls indicate nontreated WT C57BL/6 mice; Ctns−/− controls, nontreated C57BL/6 Ctns−/− mice; WT BMCs, Ctns−/− mice treated with WT BMCs; Ctns−/− BMCs, Ctns−/− mice treated with Ctns−/− BMCs; and WT MSCs, Ctns−/− mice treated with WT MSCs.
P < .05 vs wild-type mice.
P < .05 vs Ctns−/− WT BMCs.